BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19269046)

  • 1. The apparent cooperativity of some GPCRs does not necessarily imply dimerization.
    Chabre M; Deterre P; Antonny B
    Trends Pharmacol Sci; 2009 Apr; 30(4):182-7. PubMed ID: 19269046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.
    Albizu L; Balestre MN; Breton C; Pin JP; Manning M; Mouillac B; Barberis C; Durroux T
    Mol Pharmacol; 2006 Nov; 70(5):1783-91. PubMed ID: 16926282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H; Haga T
    Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1.
    Svendsen AM; Zalesko A; Kønig J; Vrecl M; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):10-7. PubMed ID: 18723073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.
    Szidonya L; Cserzo M; Hunyady L
    J Endocrinol; 2008 Mar; 196(3):435-53. PubMed ID: 18310440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphan GPCRs and their ligands.
    Civelli O; Saito Y; Wang Z; Nothacker HP; Reinscheid RK
    Pharmacol Ther; 2006 Jun; 110(3):525-32. PubMed ID: 16289308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the ligand-receptor-G protein ternary complex for GPCR drug discovery.
    Ratnala VR; Kobilka B
    Methods Mol Biol; 2009; 552():67-77. PubMed ID: 19513642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment.
    Oakley RH; Hudson CC; Sjaastad MD; Loomis CR
    Methods Enzymol; 2006; 414():50-63. PubMed ID: 17110186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization and negative cooperativity in the relaxin family peptide receptors.
    Svendsen AM; Vrecl M; Knudsen L; Heding A; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Ann N Y Acad Sci; 2009 Apr; 1160():54-9. PubMed ID: 19416159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains.
    Agnati LF; Leo G; Genedani S; Andreoli N; Marcellino D; Woods A; Piron L; Guidolin D; Fuxe K
    Brain Res Rev; 2008 Aug; 58(2):459-74. PubMed ID: 18022243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR.
    Durroux T
    Trends Pharmacol Sci; 2005 Jul; 26(7):376-84. PubMed ID: 15946747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.
    Damian M; Martin A; Mesnier D; Pin JP; Banères JL
    EMBO J; 2006 Dec; 25(24):5693-702. PubMed ID: 17139258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool.
    Behan DP; Chalmers DT
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):548-60. PubMed ID: 12825451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
    Parthier C; Reedtz-Runge S; Rudolph R; Stubbs MT
    Trends Biochem Sci; 2009 Jun; 34(6):303-10. PubMed ID: 19446460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
    Wheatley M; Simms J; Hawtin SR; Wesley VJ; Wootten D; Conner M; Lawson Z; Conner AC; Baker A; Cashmore Y; Kendrick R; Parslow RA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):717-20. PubMed ID: 17635132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled receptor dimers: functional consequences, disease states and drug targets.
    Dalrymple MB; Pfleger KD; Eidne KA
    Pharmacol Ther; 2008 Jun; 118(3):359-71. PubMed ID: 18486226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling mechanisms of GPCR ligands.
    Strange PG
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.